Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Novartis Ag (NVSEF) Assets Average (2016 - 2025)

Historic Assets Average for Novartis Ag (NVSEF) over the last 17 years, with Q4 2025 value amounting to $109.1 billion.

  • Novartis Ag's Assets Average rose 605.92% to $109.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $109.1 billion, marking a year-over-year increase of 605.92%. This contributed to the annual value of $106.6 billion for FY2025, which is 544.24% up from last year.
  • According to the latest figures from Q4 2025, Novartis Ag's Assets Average is $109.1 billion, which was up 605.92% from $105.8 billion recorded in Q3 2025.
  • Novartis Ag's Assets Average's 5-year high stood at $128.5 billion during Q1 2022, with a 5-year trough of $95.9 billion in Q2 2024.
  • Its 5-year average for Assets Average is $112.4 billion, with a median of $111.7 billion in 2023.
  • In the last 5 years, Novartis Ag's Assets Average tumbled by 1541.83% in 2024 and then skyrocketed by 651.43% in 2025.
  • Novartis Ag's Assets Average (Quarter) stood at $126.5 billion in 2021, then dropped by 6.75% to $118.0 billion in 2022, then dropped by 9.87% to $106.3 billion in 2023, then dropped by 3.23% to $102.9 billion in 2024, then grew by 6.06% to $109.1 billion in 2025.
  • Its Assets Average was $109.1 billion in Q4 2025, compared to $105.8 billion in Q3 2025 and $102.2 billion in Q2 2025.